These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34998923)

  • 1. Optimization of methionine in inhalable High-dose Spray-dried amorphous composite particles using response surface Method, infrared and low frequency Raman spectroscopy.
    Raj Adhikari B; Bērziņš K; Fraser-Miller SJ; Cavallaro A; Gordon KC; Das SC
    Int J Pharm; 2022 Feb; 614():121446. PubMed ID: 34998923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin.
    Momin MAM; Tucker IG; Das SC
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1205-1213. PubMed ID: 30990097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Physical Stability and Aerosolization of Inhalable Amorphous Ciprofloxacin Powder Formulations by Incorporating Synergistic Colistin.
    Shetty N; Ahn P; Park H; Bhujbal S; Zemlyanov D; Cavallaro A; Mangal S; Li J; Zhou QT
    Mol Pharm; 2018 Sep; 15(9):4004-4020. PubMed ID: 30028947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation.
    Raj Adhikari B; Sinha S; Lyons N; Pletzer D; Lamont I; Gordon KC; Das SC
    Eur J Pharm Biopharm; 2022 Nov; 180():260-268. PubMed ID: 36241076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
    Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
    Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis.
    Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC
    Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-Amorphization of Kanamycin with Amino Acids Improves Aerosolization.
    Adhikari BR; Bērziņš K; Fraser-Miller SJ; Gordon KC; Das SC
    Pharmaceutics; 2020 Jul; 12(8):. PubMed ID: 32751553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids improve aerosolization and chemical stability of potential inhalable amorphous Spray-dried ceftazidime for Pseudomonas aeruginosa lung infection.
    Adhikari BR; Sinha S; Gordon KC; Das SC
    Int J Pharm; 2022 Jun; 621():121799. PubMed ID: 35525472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug.
    Momin MAM; Tucker IG; Doyle CS; Denman JA; Das SC
    Int J Pharm; 2018 May; 543(1-2):318-327. PubMed ID: 29626509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N; O'Reilly NJ; Cathcart H
    Int J Pharm; 2022 Apr; 618():121657. PubMed ID: 35288220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Solid-State Properties on the Aerosolization Performance of Spray-Dried Curcumin Powders.
    Zhang Q; Li Y; Li L; Cheng Y; Yu F; Li R; Hou S
    AAPS PharmSciTech; 2023 Mar; 24(3):78. PubMed ID: 36918500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering of levodopa inhalable microparticles in combination with leucine and dipalmitoylphosphatidylcholine by spray drying technique.
    Bahrainian S; Mirmoeini MS; Gilani Z; Gilani K
    Eur J Pharm Sci; 2021 Dec; 167():106008. PubMed ID: 34530077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V; Park H; Zemlyanov D; Bhujbal SV; Ahmed MU; Azad MAK; Li J; Zhou QT
    Pharm Res; 2022 Nov; 39(11):2781-2799. PubMed ID: 35915320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation.
    Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK
    Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray dried inhalable ivacaftor co-amorphous microparticle formulations with leucine achieved enhanced in vitro dissolution and superior aerosol performance.
    Guan J; Yuan H; Yu S; Mao S; Tony Zhou Q
    Int J Pharm; 2022 Jun; 622():121859. PubMed ID: 35643348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on polymorphic forms of rifampicin for inhaled high dose delivery in tuberculosis treatment.
    Khadka P; Hill PC; Zhang B; Katare R; Dummer J; Das SC
    Int J Pharm; 2020 Sep; 587():119602. PubMed ID: 32663580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.